Legal cannabis in Lausanne strikes a blow for the black market
Two years after the launch of its pilot program for the regulated sale of cannabis, the city of Lausanne reports a significant impact on both consumer habits and local illicit trade.
According to an interim report presented this week, the legal point of sale Cann-L helped divert around 2 million Swiss francs from black market, covering approximately 20% of cannabis consumption in the capital of Vaud.
These results have been described as a turning point in the debate on Swiss drug policy, with Lausanne and its partners now calling for the trial to continue until mid-2029.
Cann-L attracts 1,750 participants and reduces dependence on illicit dealers
From opening in December 2023, Cann-L recorded over 1,750 adult participants, all residents of Lausanne and already cannabis users. The program targets a broad population: participants are aged from 18 to 79 years, with an average age of 36 years old. About 75 % are men, while most are employed (68 %) or in education or training (11 %).
Officials explain that a large majority of these participants have reduced or abandoned their purchases from illegal sources. The city estimates that around 70 % of registered consumers have turned away from the black market altogether.
«The results of the Cann-L project are very positive. Not only have we withdrawn 2 million francs from the illegal market and now cover 20 % of consumption in Lausanne, but we are also helping to protect the health of participants,» said Lausanne City Councillor Emilie Moeschler, in a press release.
Low-THC products and signs of declining consumption
Beyond the economic impact, the Lausanne report suggests that regulated access may influence the amount of cannabis consumed. Data collected during the pilot phase show a «statistically significant» drop in consumption levels over time. On average, participants reduced their consumption by around 0.2 grams per month, compared with an initial monthly average of 15.8 grams when they entered the program. The frequency of consumption also decreased.
The city also notes a clear difference in product potency compared to illegal supplies. Cannabis flowers sold via Cann-L contain an average THC content of 12,5 %, against 14,5 % on the illicit market. For resins, the average price of legal products is 17.5 % of THC, against rates exceeding 32 % on the illegal market.
These figures reinforce one of the program's public health objectives: to provide regulated cannabis with a more predictable composition and reduced risks.
Health monitoring and economic benefits for the town
Authorities are also highlighting new health-related behaviors among participants. According to the published results, nearly 100 participants consulted a doctor for the first time about their cannabis use. 131 others bought a vaporizer, This suggests an evolution towards potentially less harmful consumption methods.
From a financial point of view, the pilot project is also generating measurable benefits. Visit 2025, Cann-L reported over CHF 60,000 VAT to the federal authorities, as well as CHF 300,000 surplus, which can be reinvested in local prevention programs or research.
The city also points out that the project has created several jobs directly or indirectly linked to the regulated sales environment.
Lausanne asks Swiss authorities to extend trial until 2029
With the interim report deemed encouraging, Lausanne and Addiction Switzerland have officially asked the’Federal Office of Public Health (FOPH) authorize continuation of the trial until mid-2029.
«In addition to its significant impact on the illegal market, Cann-L allows us to better address cannabis consumption,» said Pierre-Antoine Hildbrand, Lausanne city councillor.
Project leaders say the results should inform national discussions in Berne, as Switzerland prepares its future regulatory framework. Cann-L's not-for-profit model, with its strong public health focus, is said to have helped shape the federal cannabis bill known as the LPCan.
For now, the Lausanne experience reinforces the argument that the legal and regulated sale of cannabis can weaken illegal networks while providing authorities with better tools for prevention, research and consumer protection.
These initial results also echo recent findings by highlighted in an OFDT report, which examines how Switzerland is using local pilot projects such as Cann-L as a step-by-step approach to building a future national framework for cannabis regulation.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


You must be logged in to post a comment Login